封面
市場調查報告書
商品編碼
2051431

心臟節律管理設備市場:按產品、應用、最終用戶和地區分類

Cardiac Rhythm Management Devices Market, By Product, By Application, By End Users, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,心臟節律管理設備市場規模將達到190.5億美元,2033年將達到257.6億美元。預計從2026年到2033年,該市場將以4.4%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 190.5億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 4.40% 2033年市場規模預測: 257.6億美元

心律管理包括過快、過慢或不規則心率的診斷、治療和預防。全球心血管疾病盛行率的上升和人口老化可能會推動對心律管理設備的需求。科技進步使得更小巧、可植入的設備得以研發,進而提高了病患的生活品質。然而,手術和設備的高成本可能會阻礙市場成長。心律管理設備的市場成長主要得益於產品核可的增加和新興市場業務的擴張。

市場動態

全球心臟節律管理設備市場正在成長,這主要得益於與心率相關的心血管疾病盛行率不斷上升,以及技術進步推動了精密植入式設備的研發。根據世界衛生組織統計,每年有超過1700萬人死於心血管疾病,其中絕大多數是由心律不整引起的。老年人口的成長,以及老年人心律不整的風險增加,也促進了市場成長。然而,精密植入式醫療設備的高昂成本以及相關的植入手術費用可能會阻礙市場成長。市場參與企業可以透過獲得創新醫療設備在新應用領域的核准,並透過與經銷商建立合作關係和合資企業,將業務拓展到亞太、拉丁美洲以及中東和非洲等新興市場,從而找到新的商機。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球心臟節律管理設備市場的主要參與者進行了分析:公司概況、產品系列、主要亮點、財務績效和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球心臟節律管理設備市場報告」旨在為該行業的各種相關人員提供服務,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析全球心臟節律管理設備市場中使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管趨勢
  • 收購與合作趨勢
  • 資金籌措及投資
  • PEST分析
  • 波特的分析

第4章 全球心臟節律管理設備市場:依產品分類,2021-2033年

  • 概述
  • 心律調節器
  • 去心房顫動
  • 心臟再同步治療裝置

第5章 全球心臟節律管理設備市場:依應用領域分類,2021-2033年

  • 概述
  • 鬱血性心臟衰竭
  • 心律不整
  • 心搏過緩
  • 心搏過速
  • 其他

第6章 全球心臟節律管理設備市場:依最終用戶分類,2021-2033年

  • 概述
  • 醫院
  • 心臟護理中心
  • 門診手術中心
  • 其他

第7章 全球心臟節律管理設備市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 公司簡介
    • Abbott Laboratories
    • Abiomed
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Koninklijke Philips NV
    • LivaNova PLC
    • Medtronic PLC
    • Schiller AG
    • Physio-Control, Inc.
    • Progetti Srl
    • Zoll Medical Corporation
    • Cardiac Science
    • Defibtech, LLC
    • Asahi Kasei Corporation
    • MicroPort Scientific Corporation
    • St. Jude Medical, Inc.
    • CU Medical Systems Inc.

第9章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章:調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2364

Cardiac Rhythm Management Devices Market is estimated to be valued at USD 19.05 Bn in 2026 and is expected to reach USD 25.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 19.05 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 4.40% 2033 Value Projection: USD 25.76 Bn

Cardiac rhythm management includes diagnosis, treatment, and prevention of fast, slow, or irregular heartbeats. Rising prevalence of cardiovascular diseases and growing geriatric population worldwide can boost demand for cardiac rhythm management devices. Technological advancements have enabled development of miniaturized implantable devices, offering improved quality of life to patients. However, high costs of surgical procedures and devices can hamper the market growth. Cardiac rhythm management devices market growth is driven by rising product approvals and expansions in emerging nations.

Market Dynamics

Global cardiac rhythm management devices market growth is driven by rising prevalence of cardiovascular disorders associated with heart rhythm abnormalities and technological advancements leading to development of sophisticated implantable devices. According to WHO, cardiovascular diseases account for over 17 million deaths annually, a majority of which are caused due to irregular heartbeats. Growing geriatric population also drives the market growth, as aging increases risk of developing arrhythmias. However, high costs of sophisticated implantable devices and surgical procedures to implant them can hamper the market growth. Market players can witness new opportunities by gaining approvals for innovative devices in newer applications and expanding to emerging countries in Asia Pacific, Latin America, and Middle East & Africa through distributor partnerships and JVs.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cardiac rhythm management devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global cardiac rhythm management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac rhythm management devices market

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2026 - 2033)
  • Pacemakers
  • Defibrillators
  • Cardiac Resynchronization Therapy Devices
  • Application Insights (Revenue, USD Bn, 2026 - 2033)
  • Congestive heart failure
  • Arrhythmias
  • Bradycardia
  • Tachycardia
  • Others
  • End users Insights (Revenue, USD Bn, 2026 - 2033)
  • Hospitals
  • Cardiac care centers
  • Ambulatory surgical centers
  • Others
  • Regional Insights (Revenue, USD Bn, 2026 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Abbott Laboratories
  • Abiomed
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic PLC
  • Schiller AG
  • Physio-Control, Inc.
  • Progetti Srl
  • Zoll Medical Corporation
  • Cardiac Science
  • Defibtech, LLC
  • Asahi Kasei Corporation
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • CU Medical Systems Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cardiac Rhythm Management Devices Market, By Product, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Pacemakers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Defibrillators
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cardiac Resynchronization Therapy Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Cardiac Rhythm Management Devices Market, By Application, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Congestive heart failure
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Arrhythmias
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Bradycardia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Tachycardia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Cardiac Rhythm Management Devices Market, By End User, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cardiac care centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Cardiac Rhythm Management Devices Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abiomed
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biotronik SE & Co. KG
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boston Scientific Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Koninklijke Philips NV
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LivaNova PLC
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medtronic PLC
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Schiller AG
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Physio-Control, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Progetti Srl
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zoll Medical Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cardiac Science
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Defibtech, LLC
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Asahi Kasei Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • MicroPort Scientific Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • St. Jude Medical, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CU Medical Systems Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact